Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Woodford meanwhile this week sold the last of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
longfellow95 Member Profile
 
Followed By 23
Posts 4,383
Boards Moderated 0
Alias Born 04/05/15
160x600 placeholder
CLS Holdings (CLSH) Record Sales Just Reported - Most Undervalued Cannabis Stocks InvestorsHub NewsWire - 9/10/2019 7:00:09 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:22:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 5:05:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/18/2019 6:02:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/17/2019 5:24:27 PM
Biotech Companies with Recent and Potential Near-Term Catalysts InvestorsHub NewsWire - 7/15/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 12:11:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:24:36 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/2/2019 5:23:33 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/19/2019 5:19:39 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:33:33 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:20:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2019 5:26:54 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 1/8/2019 6:04:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/20/2018 4:18:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 4:17:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/28/2018 5:28:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2018 1:44:13 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2018 5:38:07 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/15/2018 3:15:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 4:49:26 PM
longfellow95   Saturday, 08/31/19 04:26:32 AM
Re: None
Post # of 244450 
Quote:
Woodford meanwhile this week sold the last of his stake in Northwest Biotherapeutics (NWBO.O), the stock that delivered one of the earliest blows to the fund manager after he set up his own fund group five years ago.

The stock's crash from a peak of $12 a share in 2015 to 24 cents today, as the company was forced to recruit a former FBI special agent to investigate claims of financial impropriety, meant it had fallen to a tiny portion of Woodford Equity Income and the Woodford Patient Capital (WPCT) investment trust.

Woodford raised around £2.3 million from the sale of his remaining stake on Wednesday. US deep value investor Michael Bigger appeared to take the other side of the trade.



https://citywire.co.uk/funds-insider/news/woodford-buys-bat-bt-and-iag-in-ftse-100-spending-spree/a1263441

All gone then, apparently..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist